MX2010000981A - Anticuerpos para cd200 y usos de los mismos para inhibir respuestas inmune. - Google Patents

Anticuerpos para cd200 y usos de los mismos para inhibir respuestas inmune.

Info

Publication number
MX2010000981A
MX2010000981A MX2010000981A MX2010000981A MX2010000981A MX 2010000981 A MX2010000981 A MX 2010000981A MX 2010000981 A MX2010000981 A MX 2010000981A MX 2010000981 A MX2010000981 A MX 2010000981A MX 2010000981 A MX2010000981 A MX 2010000981A
Authority
MX
Mexico
Prior art keywords
inhibiting
immune responses
antibodies
inhibiting immune
cd200r
Prior art date
Application number
MX2010000981A
Other languages
English (en)
Spanish (es)
Inventor
Russell P Rother
Susan Faas Mcknight
Original Assignee
Alexion Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alexion Pharma Inc filed Critical Alexion Pharma Inc
Publication of MX2010000981A publication Critical patent/MX2010000981A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
MX2010000981A 2007-07-25 2008-07-25 Anticuerpos para cd200 y usos de los mismos para inhibir respuestas inmune. MX2010000981A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96202207P 2007-07-25 2007-07-25
PCT/US2008/009037 WO2009014745A1 (en) 2007-07-25 2008-07-25 Antibodies to cd200 and uses thereof in inhibiting immune responses

Publications (1)

Publication Number Publication Date
MX2010000981A true MX2010000981A (es) 2010-05-21

Family

ID=40001380

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010000981A MX2010000981A (es) 2007-07-25 2008-07-25 Anticuerpos para cd200 y usos de los mismos para inhibir respuestas inmune.

Country Status (9)

Country Link
US (3) USRE46323E1 (enExample)
EP (1) EP2178561A1 (enExample)
JP (4) JP2010534243A (enExample)
KR (1) KR20100041849A (enExample)
AU (1) AU2008279619B2 (enExample)
BR (1) BRPI0814644A2 (enExample)
CA (1) CA2697159C (enExample)
MX (1) MX2010000981A (enExample)
WO (1) WO2009014745A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010534243A (ja) * 2007-07-25 2010-11-04 アレクシオン ファーマシューティカルズ， インコーポレイテッド Ｃｄ２００に対する抗体および免疫応答への使用
NZ601580A (en) * 2010-02-11 2014-11-28 Alexion Pharma Inc Therapeutic methods using anti-cd200 antibodies
TW201244737A (en) 2011-02-03 2012-11-16 Alexion Pharma Inc Use of an anti-CD200 antibody for prolonging the survival of allografts
DK3150632T3 (en) 2011-06-10 2020-04-27 Canada Minister Nat Defence ANTI-RICIN ANTIBODIES AND APPLICATIONS THEREOF
US11492383B2 (en) 2011-06-24 2022-11-08 Stephen D. Gillies Light chain immunoglobulin fusion proteins and methods of use thereof
US9737598B2 (en) * 2014-06-30 2017-08-22 Regents Of The University Of Minnesota CD200 inhibitors and methods of use thereof
US20170296623A1 (en) * 2014-12-17 2017-10-19 Cellectis INHIBITORY CHIMERIC ANTIGEN RECEPTOR (iCAR OR N-CAR) EXPRESSING NON-T CELL TRANSDUCTION DOMAIN
AU2016349897B2 (en) 2015-11-03 2021-11-04 Regents Of The University Of Minnesota CD200 inhibitors and methods of use thereof
KR102379464B1 (ko) 2016-06-20 2022-03-29 키맵 리미티드 항-pd-l1 항체
WO2018102594A1 (en) * 2016-12-01 2018-06-07 Alexion Pharmaceuticals, Inc. Methods of treating solid tumors with anti-cd200 antibodies
KR101968246B1 (ko) * 2017-04-27 2019-04-11 서울대학교산학협력단 이종 각막 이식에서 항 cd20 단일클론항체 및 타클로리무스의 복합면역억제 방법
WO2019067499A1 (en) 2017-09-27 2019-04-04 Alexion Pharmaceuticals, Inc. BIOMARKER SIGNATURE FOR PREDICTING A TUMOR RESPONSE TO ANTI-CD200 THERAPY
US12139533B2 (en) 2017-12-20 2024-11-12 Alexion Pharmaceuticals, Inc. Liquid formulations of anti-CD200 antibodies
US11802154B2 (en) 2017-12-20 2023-10-31 Alexion Pharmaceuticals, Inc. Humanized anti-CD200 antibodies and uses thereof
JP7663237B2 (ja) 2019-01-14 2025-04-16 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ がん免疫療法のためのｃｄ２００ａｒリガンド
EP4296280A1 (en) 2022-06-21 2023-12-27 F. Hoffmann-La Roche AG Cd123 and cd200 as markers for the diagnosis and immune-eradication of leukemic stem cells (lscs)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1032662E (pt) * 1997-11-07 2006-07-31 Trillium Therapeutics Inc Metodos e composicoes para imunomodulacao.
US7223729B2 (en) * 1997-11-07 2007-05-29 Trillium Therapeutics Inc. Methods of treating allergy by administering a CD200 protein
US20060057651A1 (en) * 2000-12-08 2006-03-16 Bowdish Katherine S Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
WO2004060295A2 (en) 2002-12-27 2004-07-22 Schering Corporation Methods of inducing and maintaining immune tolerance
EP2463305B1 (en) * 2006-01-12 2016-05-11 Alexion Pharmaceuticals, Inc. Antibodies to OX-2/CD200 and uses thereof
CA2694121C (en) 2007-07-25 2016-06-07 Alexion Pharmaceuticals, Inc. Methods and compositions for treating autoimmune disease
JP2010534243A (ja) * 2007-07-25 2010-11-04 アレクシオン ファーマシューティカルズ， インコーポレイテッド Ｃｄ２００に対する抗体および免疫応答への使用

Also Published As

Publication number Publication date
AU2008279619A1 (en) 2009-01-29
JP2015172090A (ja) 2015-10-01
BRPI0814644A2 (pt) 2015-01-27
US20120321625A1 (en) 2012-12-20
JP2010534243A (ja) 2010-11-04
US8252285B2 (en) 2012-08-28
CA2697159A1 (en) 2009-01-29
EP2178561A1 (en) 2010-04-28
CA2697159C (en) 2017-02-14
USRE46323E1 (en) 2017-02-28
US20100291085A1 (en) 2010-11-18
AU2008279619B2 (en) 2013-11-14
JP2016117762A (ja) 2016-06-30
WO2009014745A1 (en) 2009-01-29
KR20100041849A (ko) 2010-04-22
US8637014B2 (en) 2014-01-28
JP2013163695A (ja) 2013-08-22
JP5926702B2 (ja) 2016-05-25

Similar Documents

Publication Publication Date Title
HRP20190220T1 (hr) Anti-il-23 protutijela, pripravci, postupci i upotrebe
MY161909A (en) Anti-her3 antibodies and uses thereof
GB0515353D0 (en) Food
TN2010000213A1 (en) Wise binding antibodies and epitopes
PH12013502230A1 (en) Multispecific antibodies
TW200732349A (en) Anti-OX40L antibodies and methods using same
SG10201405377XA (en) Compositions and methods for antibodies targeting complement protein c5
MX345909B (es) Anticuerpos anti-fgfr3 y métodos que los utilizan.
MY159679A (en) Antibodies binding preferentially human csf1r extracellular domain 4 and their use
MY160736A (en) Bivalent, bispecific antibodies
MX2010007767A (es) Anticuerpos manipulados con cisteina para conjugacion especifica de sitio.
IL236427A0 (en) Human anti-23-il antibodies, preparations, methods and uses
MY154956A (en) Chimeric adenoviral vectors
MX2009003774A (es) Anticuerpos para linfotoxina-alfa.
NO20083397L (no) Anti-EphB4-antistoffer og fremgangsmater for anvendelse av disse
MX2010006396A (es) Anticuerpos bivalentes, biespecificos.
MX339015B (es) Anticuerpos que se fijan a tweak.
MY173526A (en) Novel anti-?5?1 antibodies and uses thereof
PH12013500933A1 (en) Methods and compositions for neural disease immunotherapy
MX2009006879A (es) Anticuerpos contra el cd200r.
EP2663330A1 (en) Anti-tlr4 antibodies and methods of use thereof
MX2009013170A (es) Particulas de silice y metodos para prepararlas y utilizarlas.
TW200738751A (en) Anti-EphrinB2 antibodies and methods using same
MX2010000979A (es) Metodos y composiciones para tratar enfermedad autoinmune.
UA99332C2 (en) Herbicidal combinations having diflufenican and pinoxaden and use thereof

Legal Events

Date Code Title Description
FG Grant or registration